MAPS MAPS
  • About
  • Research
  • News
  • Resources
  • Participate
  • Donate
  • Store

MAPS Bulletin Autumn 1990: Vol. 01, No. 3 What and Who is MAPS?

Download this entire issue or browse individual articles by title below.

 
   

 

  What and Who is MAPS? Rick Doblin, Ph.D.
  The Two Functions of MAPS Rick Doblin, Ph.D.
  Thoughts About the Ethics of Animal Research Rick Doblin, Ph.D.
  MDMA Neurotoxicity Overview Rick Doblin, Ph.D.
  Preliminary Findings from Primate Neurotoxicity Studies Rick Doblin, Ph.D.
  Dr. Nichols Confirms that Prozac Blocks MDMA Neurotoxicity Rick Doblin, Ph.D.
  Requested - Subjective Reports of the Prozac / MDMA Combinations Rick Doblin, Ph.D.
  Findings From the Two NIDA-Funded MDMA Human Studies Rick Doblin, Ph.D.
  A Call for Volunteers for the Johns Hopkins MDMA Human Neurotoxicity Study

Rick Doblin, Ph.D.

  Update on Swiss Psychedelic Research

Rick Doblin, Ph.D.

  Unsuccessful MAPS Attempts at Collaborative Research

Rick Doblin, Ph.D.

  Swiss Psychedelic Usage Halted - Resumption Possible But Not Certain

Rick Doblin, Ph.D.

  New Opportunities for MDMA Research in Czechoslovakia

Rick Doblin, Ph.D.

  The MAPS International Research Methodology Conference

Rick Doblin, Ph.D.

  Pharmaceutical Companies Study the Market For Psychedelics

Rick Doblin, Ph.D.

  MAPS' Research Agenda and Financial Requests

Rick Doblin, Ph.D.

Stay Connected via Email

Subscribe for research updates, event announcements, news, multimedia, and more from the fast-growing fields of psychedelic and medical marijuana science, therapy, and spirituality.

Your email address:


Support Us

Donate Now

MAPS

We are a 501(c)(3) non-profit research and educational organization developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.

Watch videos from Psychedelic Science 2017.

Media

  • January 12, 2021 Sarasota Herald-Tribune: Can Psychedelics Save the Planet? New College Alum Rick Doblin’s Mission is to Find Out
  • January 2, 2021 Wired: Big Pharma is About to Tune in to the Potential of Psychedelics
  • December 16, 2020 Globes English: A Trip to Better Management Skills?

About Us

  • Mission
  • Board of Directors
  • Staff
  • Financial Reports
  • MAPS Public Benefit Corporation (MAPS PBC)
  • 501(c)(3) & Bylaws
  • FAQ

Contact Us

3141 Stevens Creek Blvd #40563
San Jose, CA 95117
Phone: 831-429-MDMA (6362)
Fax: 831-429-6370
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Requests

Log in to your account


Privacy Policy | Donate

facebook twitter instagram youtube
google pinterest tumbler linkedin
  • About
    • Mission
    • Board of Directors
    • Staff
    • Financial Reports
    • MAPS Public Benefit Corporation (MPBC)
    • 501(c)(3), EIN, and Bylaws
    • Privacy Policy
    • FAQ
  • Research
    • MDMA-Assisted Therapy
    • LSD-Assisted Psychotherapy
    • Ibogaine Therapy for Drug Addiction
    • Ayahuasca-Assisted Treatment
    • Medical Marijuana
    • Other Psychedelic Research
    • Research articles
  • News
    • MAPS Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • MAPS Podcast
    • Multimedia Library
    • Posts
    • MAPS Podcast
    • Emails
  • Resources
    • Brochures
    • Psychedelic Harm Reduction
    • Research Papers
    • Psychedelic Integration List
    • Psychedelic Bibliography
    • Free Books and Essays
    • Links
    • For Students
    • MAPS Forums on Bluelight
    • Psychedelic Science 2017 Videos
  • Participate
    • Global Psychedelic Dinners
    • Featured Events
    • Event Calendar
    • Volunteer
    • Global Psychedelic Dinners
    • Internships
    • MDMA Therapy Training Program
    • Careers
    • Participate in Research
  • Donate
    • Make a Gift
    • Why Give?
    • Funding Priorities
    • Other Ways to Give
  • Store
    • Books
    • Clothing and Accessories
    • DVDs
    • Historic Artifacts
    • Art Gallery
    • MAPS Bulletin: Back Issues